A Structure-Based View on ABC-Transporter Linked to Multidrug Resistance

10.01.2023

Happy New Year! 2023 is already off to a great start with the first published paper this year.

Huang, J.; Ecker, G.F. A Structure-Based View on ABC-Transporter Linked to Multidrug Resistance. Molecules 2023, 28, 495.

DOI

https://doi.org/10.3390/molecules28020495

Abstract

The discovery of the first ATP-binding cassette (ABC) transporter, whose overexpression in cancer cells is responsible for exporting anticancer drugs out of tumor cells, initiated enormous efforts to overcome tumor cell multidrug resistance (MDR) by inhibition of ABC-transporter. Because of its many physiological functions, diverse studies have been conducted on the mechanism, function and regulation of this important group of transmembrane transport proteins. In this review, we will focus on the structural aspects of this transporter superfamily. Since the resolution revolution of electron microscope, experimentally solved structures increased rapidly. A summary of the structures available and an overview of recent structure-based studies are provided. More specifically, the artificial intelligence (AI)-based predictions from AlphaFold-2 will be discussed.

Rights & permissions

Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://cre‐ ativecommons.org/licenses/by/4.0/).

Keywords

structure‐based studies; ABC transporter; multidrug resistance (MDR); cancer therapy

 

 

© 2023 by the authors. Li‐

censee MDPI, Basel, Switzerland.

 More News

Open Access
 

Are you curious what is known about SLCs? And how they are related? We are enthusiastic about our manuscript presenting the data- and...

News
 

Tarik Ćerimagić successfully defended his master thesis: "A Multi-Task Deep Neural Network Approach for Data Imputation of SLC Transporter...

News
 

On July 10th, 2024 our colleague Aljoša successfully defended his PhD thesis: "Machine Learning Approaches for Off-Target and Bioactivity...